How much funding has AbSci raised?

AbSci has raised $279.5M in total funding, most recently a Growth Equity round.

Where is AbSci headquartered?

AbSci is headquartered in Vancouver, Washington, United States.

What industry is AbSci in?

AbSci operates in Artificial Intelligence, Biotech, Drug Discovery, Healthcare.

AbSci

IPO

Creating better biologics for patients, faster.

Public · Vancouver, United States · Founded 2011 · $279.5M raised

Artificial Intelligence

Biotech

Drug Discovery

Healthcare

Headquarters: Vancouver, Washington
Employees: 201–500
Founded: 2011
Business Model: B2B
Website: absci.com

Total Funding: $279.5M
Last Round: $64.0M Growth EquityAug 2025
Rounds: 5
Type: Public

About

Absci is a data-first generative AI drug creation company combining AI with scalable wet lab technologies to design better biologics. Their Integrated Drug Creation Platform uses deep learning and synthetic biology to go from AI-designed antibodies to wet lab-validated candidates in as little as six weeks, accelerating discovery against difficult-to-drug targets.

Summary

AbSci is an Artificial Intelligence company based in Vancouver, United States, founded in 2011. It has raised $279.5M in total across 5 rounds, most recently a $64.0M Growth Equity round in Aug 2025.

LinkedIn X (Twitter)GitHub